EXPRESSION OF MUC APOMUCINS IN NORMAL PANCREAS AND PANCREATIC TUMOURS

The epithelial expression of apomucins MUC1, MUC2, MUC3, and MUC5/6 was examined in normal pancreas and in pancreatic lesions, using immunohistochemical methods. In normal pancreas (n=5), MUC1 apomucin was expressed in ducts and some acini, but there was no expression of MUC2, MUC3, or MUC5/6. In chronic pancreatitis (n=5), MUC1 apomucin was expressed, but expression of the other apomucins was not noted. However, mucous hyperplastic foci of pancreatic ducts expressed MUC5/6 apomucin in 2/5 cases (40 per cent). In intraductal papillary‐mucinous neoplasm (IPMN) of the pancreas (n=9), MUC1, MUC2, MUC3, and MUC5/6 apomucins were expressed in 8/9 (89 per cent), 0/9 (0 per cent), 4/9 (44 per cent), and 9/9 (100 per cent) cases, respectively. In pancreatic mucinous cystadenoma (n=8), MUC1, MUC2, MUC3, and MUC5/6 apomucins were expressed in 7/8 (88 per cent), 0/8 (0 per cent), (25 per cent), and 3/8 (38 per cent) cases, respectively. In invasive ductal adenocarcinoma of the pancreas (n=25), expression of MUC1, MUC2, MUC3, and MUC5/6 apomucins was found in 25/25 (100 per cent), 1/25 (4 per cent), 20/25 (80 per cent), and 24/25 (96 per cent) cases, respectively. Atypical mucous duct hyperplasia near cancer cells consistently expressed MUC1 apomucin and occasionally expressed MUC3 and MUC5/6. In positive cases, MUC1 apomucin expression was noted in the cell membrane facing the ductal or neoplastic lumina, while expression of MUC2, MUC3, and MUC5/6 apomucins was found in the cytoplasm. These results suggest that MUC3 and MUC5/6 apomucins newly emerge during the neoplastic transformation of pancreatic mucinous cystadenoma and IPMN and during pancreatic ductal carcinogenesis, while MUC1 apomucin remains positive and MUC2 apomucin remains almost negative during neoplastic transformation.

[1]  D. Klimstra,et al.  K-ras mutations in pancreatic ductal proliferative lesions. , 1994, The American journal of pathology.

[2]  K. Satoh,et al.  Infrequent stromal expression of gelatinase A and intact basement membrane in intraductal neoplasms of the pancreas. , 1994, Gastroenterology.

[3]  F. Real,et al.  Differential apomucin expression in normal and neoplastic human gastrointestinal tissues. , 1994, Gastroenterology.

[4]  Y. Kim,et al.  Localization of mucin (MUC2 and MUC3) messenger RNA and peptide expression in human normal intestine and colon cancer. , 1994, Gastroenterology.

[5]  J. Cameron,et al.  Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma. , 1994, The American journal of pathology.

[6]  C. Balagué,et al.  Altered expression of MUC2, MUC4, and MUC5 mucin genes in pancreas tissues and cancer cell lines. , 1994, Gastroenterology.

[7]  Y. Kim,et al.  Immunohistochemical study of mucin carbohydrates and core proteins in human ovarian tumors. , 1994, Human pathology.

[8]  A. Biesbrock,et al.  Molecular cloning, sequence, and specificity of expression of the gene encoding the low molecular weight human salivary mucin (MUC7). , 1993, The Journal of biological chemistry.

[9]  N. Porchet,et al.  Degenerate 87-base-pair tandem repeats create hydrophilic/hydrophobic alternating domains in human mucin peptides mapped to 11p15. , 1993, The Biochemical journal.

[10]  H. Sasano,et al.  An immunohistochemical study of the c‐erbB‐2 oncogene product in intraductal mucin‐hypersecreting neoplasms and in ductal cell carcinomas of the pancreas , 1993, Cancer.

[11]  Y. S. Kim,et al.  Immunohistochemical study of mucin carbohydrates and core proteins in human pancreatic tumors , 1993, Cancer.

[12]  R. Dahiya,et al.  Mucin synthesis and secretion in various human epithelial cancer cell lines that express the MUC-1 mucin gene. , 1993, Cancer research.

[13]  W. Kuo,et al.  Human gastric mucin. Identification of a unique species by expression cloning. , 1993, The Journal of biological chemistry.

[14]  A. Yanagisawa,et al.  Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation. , 1993, Cancer research.

[15]  R. Dahiya,et al.  Heterogeneity of mucin gene expression in normal and neoplastic tissues. , 1993, Cancer research.

[16]  T. Takahashi,et al.  The mucus‐hypersecreting tumor of the pancreas. Development and extension visualized by three‐dimensional computerized mapping , 1992, Cancer.

[17]  J. Devière,et al.  Intraductal mucin-hypersecreting neoplasms of the pancreas. A clinicopathologic study of eight patients. , 1991, Gastroenterology.

[18]  R. Dahiya,et al.  Differential mucin gene expression in human pancreatic and colon cancer cells. , 1991, The Biochemical journal.

[19]  M. Gross,et al.  Molecular cloning and chromosomal localization of a novel human tracheo-bronchial mucin cDNA containing tandemly repeated sequences of 48 base pairs. , 1991, Biochemical and biophysical research communications.

[20]  D. Swallow,et al.  Molecular cloning of cDNAs derived from a novel human intestinal mucin gene. , 1990, Biochemical and biophysical research communications.

[21]  G. Klöppel,et al.  Intraductal papillary neoplasms of the pancreas. A clinicopathologic study of six patients , 1989, Cancer.

[22]  Y. Kim,et al.  Molecular cloning of human intestinal mucin cDNAs. Sequence analysis and evidence for genetic polymorphism. , 1989, The Journal of biological chemistry.

[23]  J. Taylor‐Papadimitriou,et al.  Cloning of partial cDNA encoding differentiation and tumor-associated mucin glycoproteins expressed by human mammary epithelium. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Oertel,et al.  Mucinous cystic neoplasms of the pancreas with overt and latent malignancy (cystadenocarcinoma and cystadenoma). A clinicopathologic study of 41 cases. , 1978, American journal of clinical pathology.

[25]  N. Lemoine,et al.  Ki-ras oncogene activation in preinvasive pancreatic cancer. , 1992, Gastroenterology.